Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
European Archives of Oto-Rhino-Laryngology · 2024-06 · 281 (6) · 3017-3023
DOI: 10.1007/s00405-024-08461-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 12.02.2024. Verfasst von Cecilia Rosso und 13 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy. rosso.cecilia1@gmail.co…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Asthma, Sinusitis, Nasal Polyps. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Milano.
Abstract (Originalsprache)
Purpose
Nowadays, several efficacious biologic drugs are used for severe asthma with or without chronic rhinosinusitis with nasal polyps (CRSwNP). However, it has been observed that not all comorbid patients (asthma/CRSwNP) receiving biologic treatment for asthma experience satisfactory control of both conditions equally.
Methods
We selected 20 patients who had both severe asthma and comorbid CRSwNP under biological treatment with benralizumab, omalizumab or mepolizumab with adequate control of asthma but inadequate control of nasal symptoms. Patients were switched to dupilumab and outcomes were evaluated at baseline (T0), at 3 months (T1), at 6 months (T2), at 12 months (T3) and finally at 18 months (T4). Data were collected at each time point including blood tests measuring eosinophil levels and total IgE, SNOT22, ACT, NPS score, rhinomanometry, olfactory testing, and nasal cytology.
Results
The results showed an overall improvement in all the outcomes. Peripheral eosinophilia was observed consistently with existing literature. All patients registered an improvement in sinonasal outcomes, while only one patient had a worsening of asthma. Three patients interrupted the therapy due to various causes: poor asthma control, onset of psoriasis and thrombocytopenia.
Conclusions
The response to a biologic treatment for CRSwNP control may be heterogenous and it seems that patients may benefit from switching improving control in equal measure in the upper and lower airway. Further studies to explore the endotype/phenotype which best fits with each biologic are mandatory to personalize the therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy. rosso.cecilia1@gmail.com.
- Department of Otolaryngology, San Paolo Hospital, University of Milan, via di Rudinì 8, 20154, Milan, Italy. rosso.cecilia1@gmail.com.
- Unit of Otorhinolaryngology-Head and Neck Surgery, A. Gemelli Hospital Foundation IRCCS, 00168, Rome, Italy.
- Otolaryngology Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy.
- Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
- Pulmonology Department, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Förderung
- Università degli Studi di Milano
Zitieren
APA
Rosso, C., De Corso, E., Conti, V., Nitro, L., Saibene, A. M., Parazzini, E., Rinaldo, R., De Pascalis, S., Arnone, F., Centanni, S., Montuori, C., D'Auria, L. M., Felisati, G., & Pipolo, C. (2024). Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP. European Archives of Oto-Rhino-Laryngology, 281(6), 3017-3023. https://doi.org/10.1007/s00405-024-08461-y
Vancouver
Rosso C, De Corso E, Conti V, Nitro L, Saibene AM, Parazzini E, et al. Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP. European Archives of Oto-Rhino-Laryngology. 2024;281(6):3017-3023. doi:10.1007/s00405-024-08461-y
BibTeX
@article{Rosso2024,
author = {Rosso, Cecilia and De Corso, Eugenio and Conti, Valerio and Nitro, Letizia and Saibene, Alberto Maria and Parazzini, Elena and Rinaldo, Rocco and De Pascalis, Sabrina and Arnone, Flavio and Centanni, Stefano and Montuori, Claudio and D'Auria, Leandro Maria and Felisati, Giovanni and Pipolo, Carlotta},
title = {Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2024},
volume = {281},
number = {6},
pages = {3017--3023},
doi = {10.1007/s00405-024-08461-y}
}
EUVIMED